Cargando…

Efficacy of Bivalirudin for Therapeutic Anticoagulation in COVID-19 Patients Requiring ECMO Support

OBJECTIVES: The Coronavirus Disease 2019 (COVID-19) pandemic has been associated with cases of refractory acute respiratory distress syndrome (ARDS) sometimes requiring support with extracorporeal membrane oxygenation (ECMO). Bivalirudin can be used for anticoagulation in patients on ECMO support, b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trigonis, Russell, Smith, Nikki, Porter, Shelley, Anderson, Eve, Jennings, Mckenna, Kapoor, Rajat, Hage, Chadi, Moiz, Salwa, Garcia, Jose, Rahman, Omar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526440/ https://www.ncbi.nlm.nih.gov/pubmed/34782234 http://dx.doi.org/10.1053/j.jvca.2021.10.026

Ejemplares similares

Is it time to switch to bivalirudin for ECMO anticoagulation?
por: Navaei, Amir, et al.
Publicado: (2023)

Bivalirudin and post-cardiotomy ECMO: a word of caution
por: Ranucci, Marco
Publicado: (2012)

Selection of an Aptamer Antidote to the Anticoagulant Drug Bivalirudin
por: Martin, Jennifer A., et al.
Publicado: (2013)

Bivalirudin Anticoagulation in Extracorporeal Membrane Oxygenation (ECMO) for Severe Coronaviral Disease (COVID-19) Related Acute Respiratory Distress Syndrome (ARDS)
por: Kumar, S., et al.
Publicado: (2022)

Primary bivalirudin anticoagulation for patients with an implantable ventricular assist device
por: Pieri, M, et al.
Publicado: (2014)

Periprocedural anticoagulation in transcatheter aortic valve replacement: Heparin vs bivalirudin
por: Minhas, Abdul Mannan Khan, et al.
Publicado: (2017)

Bivalirudin-based versus conventional heparin anticoagulation for postcardiotomy extracorporeal membrane oxygenation
por: Ranucci, Marco, et al.
Publicado: (2011)

Bivalirudin or heparin: which anticoagulation strategy for critically ill cardiac surgery patients?
por: Pappalardo, F, et al.
Publicado: (2014)

Bivalirudin for Maintenance Anticoagulation During Venovenous Extracorporeal Membrane Oxygenation for COVID-19
por: Seelhammer, Troy G., et al.
Publicado: (2021)

Heparin-based versus bivalirudin-based anticoagulation in pediatric extracorporeal membrane oxygenation: A systematic review
por: Valdes, Carlos A., et al.
Publicado: (2023)

The Rise and Fall of Anticoagulation with Bivalirudin During Percutaneous Coronary Interventions: A Review Article
por: Andreou, Constantinos, et al.
Publicado: (2017)

Anticoagulation on extracorporeal membrane oxygenation (ECMO)
por: Khilnani, Praveen
Publicado: (2017)

The Emerging Role of Bivalirudin for Therapeutic Anticoagulation in Patients With Coronavirus Disease 2019 Requiring Extracorporeal Membrane Oxygenation Support: Is It Time to Change the Routine Practice?
por: Tahan, Mohamed R. El
Publicado: (2022)

EFFECT OF HEPARIN AND BIVALIRUDIN ON THE KINETICS OF CLOT FORMATION: VISCOELASTIC COAGULATION TESTING
por: Hasija, Suruchi, et al.
Publicado: (2017)

Bivalirudin in percutaneous coronary intervention
por: Lehman, Sam J, et al.
Publicado: (2006)

Superiority of bivalirudin over heparin anticoagulation therapy for extracorporeal membrane oxygenation? Too early to draw conclusions
por: Gu, Jie, et al.
Publicado: (2023)

Argatroban for an alternative anticoagulant in HIT during ECMO
por: Rougé, Alain, et al.
Publicado: (2017)

Comparison of net adverse clinical events between bivalirudin and heparin as anticoagulants for percutaneous coronary intervention in Chinese patients
por: Chai, Lina, et al.
Publicado: (2023)

Bivalirudin in Combination with Heparin to Control Mesenchymal Cell Procoagulant Activity
por: Stephenne, Xavier, et al.
Publicado: (2012)

The Efficacy and Safety of Bivalirudin Versus Heparin in the Anticoagulation Therapy of Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis
por: Ma, Min, et al.
Publicado: (2022)

Impact of Diabetes Mellitus on One-Year Clinical Outcomes in Patients Anticoagulated with Bivalirudin Undergoing Elective Percutaneous Coronary Intervention
por: Li, Yulong, et al.
Publicado: (2022)

ECMO for a polytrauma patient without systemic anticoagulation
por: Abdelaty, Mohamed, et al.
Publicado: (2017)

Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO
por: Chlebowski, Meghan M., et al.
Publicado: (2020)

Anticoagulation Management in High Bleeding-Risk ECMO in Adults
por: De Paulis, Stefano, et al.
Publicado: (2022)

Successful intraprocedural anticoagulation with bivalirudin during pulmonary vein isolation in a patient with known heparin-induced thrombocytopenia type II
por: Bellmann, Barbara, et al.
Publicado: (2016)

Quantitation of bivalirudin, a novel anticoagulant peptide, in human plasma by LC–MS/MS: Method development, validation and application to pharmacokinetics
por: Li, Xiao-Jiao, et al.
Publicado: (2013)

Management of Bivalirudin Anticoagulation Therapy for Extracorporeal Membrane Oxygenation in Heparin-Induced Thrombocytopenia: A Case Report and a Systematic Review
por: Zhong, Han, et al.
Publicado: (2020)

Role of echocardiography in ECMO
por: Kapoor, Poonam Malhotra
Publicado: (2017)

Anticoagulation in Neonatal ECMO: An Enigma Despite a Lot of Effort!
por: Cashen, Katherine, et al.
Publicado: (2019)

The Role of Excessive Anticoagulation and Missing Hyperinflammation in ECMO-Associated Bleeding
por: Rajsic, Sasa, et al.
Publicado: (2022)

Update on Anticoagulation Strategies in Patients with ECMO—A Narrative Review
por: Šoltés, Ján, et al.
Publicado: (2023)

Bivalirudin for cardiopulmonary bypass in a patient with heparin allergy
por: Boysan, Emre, et al.
Publicado: (2023)

Bivalirudin Anticoagulant Therapy With or Without Platelet Glycoprotein IIb/IIIa Inhibitors During Transcatheter Coronary Interventional Procedures: A Meta-Analysis
por: Li, Jiabei, et al.
Publicado: (2015)

Anticoagulation strategies in COVID-19 infected patients receiving ECMO support
por: Diaz, Dayne, et al.
Publicado: (2023)

Safety, efficiency and cost effectiveness of Bivalirudin: A systematic review
por: Mehrzad, Melorin, et al.
Publicado: (2017)

Bivalirudin in Patients Undergoing PCI: State of Art and Future Perspectives.
por: Galasso, G, et al.
Publicado: (2016)

A Review of Bivalirudin for Pediatric and Adult Mechanical Circulatory Support
por: Taylor, Tori, et al.
Publicado: (2020)

Extracorporeal Membrane Oxygenation Complications in Heparin- and Bivalirudin-Treated Patients
por: Giuliano, Katherine, et al.
Publicado: (2021)

Ethylene Glycol Intoxication Requiring ECMO Support
por: Rosen, Raphael, et al.
Publicado: (2021)

1478. Impact of Short versus Long Treatment Durations for Respiratory Tract Infections Caused by Non-fermenting Gram-negative Bacilli in Lung Transplant Recipients
por: Derringer, Jon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a6isgelv3g789gg8qh04s9qp7b